INITIAL FILING ON SCHEDULE 13G

Company

Oncotelic Therapeutics, Inc.

Filed

January 21, 2004

Accession Number

0000899140-04-000049

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →